was read the article
array:23 [ "pii" => "S2173574314001129" "issn" => "21735743" "doi" => "10.1016/j.reumae.2014.03.020" "estado" => "S300" "fechaPublicacion" => "2015-01-01" "aid" => "672" "copyright" => "Elsevier España, S.L.U.. All rights reserved" "copyrightAnyo" => "2014" "documento" => "simple-article" "subdocumento" => "crp" "cita" => "Reumatol Clin. 2015;11:9-11" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2574 "formatos" => array:3 [ "EPUB" => 64 "HTML" => 2190 "PDF" => 320 ] ] "Traduccion" => array:1 [ "es" => array:18 [ "pii" => "S1699258X14000801" "issn" => "1699258X" "doi" => "10.1016/j.reuma.2014.03.004" "estado" => "S300" "fechaPublicacion" => "2015-01-01" "aid" => "672" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "subdocumento" => "crp" "cita" => "Reumatol Clin. 2015;11:9-11" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 14354 "formatos" => array:3 [ "EPUB" => 202 "HTML" => 12096 "PDF" => 2056 ] ] "es" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original breve</span>" "titulo" => "¿Es seguro realizar infiltraciones o aspiraciones articulares en pacientes anticoagulados con acenocumarol?" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "9" "paginaFinal" => "11" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Is it safe to perform joint infiltrations or aspirations in patients anticoagulated with acenocoumarol?" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Carlos Guillen Astete, Alina Boteanu, Carmen Medina Quiñones, Nuria Garcia Montes, Fernando Roldan Moll, César Carballo Carmano, Antonio Zea Mendoza" "autores" => array:7 [ 0 => array:2 [ "nombre" => "Carlos" "apellidos" => "Guillen Astete" ] 1 => array:2 [ "nombre" => "Alina" "apellidos" => "Boteanu" ] 2 => array:2 [ "nombre" => "Carmen" "apellidos" => "Medina Quiñones" ] 3 => array:2 [ "nombre" => "Nuria" "apellidos" => "Garcia Montes" ] 4 => array:2 [ "nombre" => "Fernando" "apellidos" => "Roldan Moll" ] 5 => array:2 [ "nombre" => "César" "apellidos" => "Carballo Carmano" ] 6 => array:2 [ "nombre" => "Antonio" "apellidos" => "Zea Mendoza" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2173574314001129" "doi" => "10.1016/j.reumae.2014.03.020" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574314001129?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X14000801?idApp=UINPBA00004M" "url" => "/1699258X/0000001100000001/v2_201706020231/S1699258X14000801/v2_201706020231/es/main.assets" ] ] "itemSiguiente" => array:18 [ "pii" => "S2173574315000039" "issn" => "21735743" "doi" => "10.1016/j.reumae.2014.02.015" "estado" => "S300" "fechaPublicacion" => "2015-01-01" "aid" => "662" "copyright" => "Elsevier España, S.L.U." "documento" => "article" "subdocumento" => "fla" "cita" => "Reumatol Clin. 2015;11:12-6" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1953 "formatos" => array:3 [ "EPUB" => 61 "HTML" => 1458 "PDF" => 434 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Rheumatoid arthritis-associated interstitial lung disease: Lung inflammation evaluated with high resolution computed tomography scan is correlated to rheumatoid arthritis disease activity" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "12" "paginaFinal" => "16" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Enfermedad intersticial pulmonar asociada a Artritis Reumatoide: La inflamación pulmonar evaluada mediante tomografía computarizada de alta resolución correlaciona con la actividad de la enfermedad de Artritis Reumatoide" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1206 "Ancho" => 1633 "Tamanyo" => 82885 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Spearman's rank correlation coefficient for ground-glass and CDAI scores (<span class="elsevierStyleItalic">r<span class="elsevierStyleInf">s</span></span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.3767) (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.0281).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Renzo Pérez-Dórame, Mayra Mejía, Heidegger Mateos-Toledo, Jorge Rojas-Serrano" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Renzo" "apellidos" => "Pérez-Dórame" ] 1 => array:2 [ "nombre" => "Mayra" "apellidos" => "Mejía" ] 2 => array:2 [ "nombre" => "Heidegger" "apellidos" => "Mateos-Toledo" ] 3 => array:2 [ "nombre" => "Jorge" "apellidos" => "Rojas-Serrano" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1699258X14000540" "doi" => "10.1016/j.reuma.2014.02.007" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X14000540?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574315000039?idApp=UINPBA00004M" "url" => "/21735743/0000001100000001/v1_201501160858/S2173574315000039/v1_201501160858/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S2173574314000872" "issn" => "21735743" "doi" => "10.1016/j.reumae.2014.02.006" "estado" => "S300" "fechaPublicacion" => "2015-01-01" "aid" => "667" "copyright" => "Elsevier España, S.L.U." "documento" => "article" "subdocumento" => "fla" "cita" => "Reumatol Clin. 2015;11:3-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 3501 "formatos" => array:3 [ "EPUB" => 60 "HTML" => 2861 "PDF" => 580 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Special Article</span>" "titulo" => "Recommendations for the Use of Methotrexate in Rheumatoid Arthritis: Up and Down Scaling of the Dose and Administration Routes" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "3" "paginaFinal" => "8" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Recomendaciones para el uso del metotrexato en artritis reumatoide: incremento y reducción de dosis y vías de administración" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2094 "Ancho" => 2491 "Tamanyo" => 250662 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Selection of citations made from the initial search to the writing of the article.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Jesús Tornero Molina, Francisco Javier Ballina García, Jaime Calvo Alén, Miguel Ángel Caracuel Ruiz, Jordi Carbonell Abelló, Antonio López Meseguer, José Vicente Moreno Muelas, Trinidad Pérez Sandoval, Jesús Quijada Carrera, Pilar Trenor Larraz, Antonio Zea Mendoza" "autores" => array:11 [ 0 => array:2 [ "nombre" => "Jesús" "apellidos" => "Tornero Molina" ] 1 => array:2 [ "nombre" => "Francisco Javier" "apellidos" => "Ballina García" ] 2 => array:2 [ "nombre" => "Jaime" "apellidos" => "Calvo Alén" ] 3 => array:2 [ "nombre" => "Miguel Ángel" "apellidos" => "Caracuel Ruiz" ] 4 => array:2 [ "nombre" => "Jordi" "apellidos" => "Carbonell Abelló" ] 5 => array:2 [ "nombre" => "Antonio" "apellidos" => "López Meseguer" ] 6 => array:2 [ "nombre" => "José Vicente" "apellidos" => "Moreno Muelas" ] 7 => array:2 [ "nombre" => "Trinidad" "apellidos" => "Pérez Sandoval" ] 8 => array:2 [ "nombre" => "Jesús" "apellidos" => "Quijada Carrera" ] 9 => array:2 [ "nombre" => "Pilar" "apellidos" => "Trenor Larraz" ] 10 => array:2 [ "nombre" => "Antonio" "apellidos" => "Zea Mendoza" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1699258X1400059X" "doi" => "10.1016/j.reuma.2014.02.012" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X1400059X?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574314000872?idApp=UINPBA00004M" "url" => "/21735743/0000001100000001/v1_201501160858/S2173574314000872/v1_201501160858/en/main.assets" ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Brief report</span>" "titulo" => "Is It Safe to Perform Joint Infiltrations or Aspirations in Patients Anticoagulated With Acenocoumarol?" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "9" "paginaFinal" => "11" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Carlos Guillen Astete, Alina Boteanu, Carmen Medina Quiñones, Nuria Garcia Montes, Fernando Roldan Moll, César Carballo Carmano, Antonio Zea Mendoza" "autores" => array:7 [ 0 => array:4 [ "nombre" => "Carlos" "apellidos" => "Guillen Astete" "email" => array:2 [ 0 => "caranguillen@gmail.com" 1 => "cguillen.hrc@salud.madrid.org" ] "referencia" => array:4 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] 3 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Alina" "apellidos" => "Boteanu" "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 2 => array:3 [ "nombre" => "Carmen" "apellidos" => "Medina Quiñones" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 3 => array:3 [ "nombre" => "Nuria" "apellidos" => "Garcia Montes" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 4 => array:3 [ "nombre" => "Fernando" "apellidos" => "Roldan Moll" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 5 => array:3 [ "nombre" => "César" "apellidos" => "Carballo Carmano" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 6 => array:3 [ "nombre" => "Antonio" "apellidos" => "Zea Mendoza" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "Servicio de Reumatología, Hospital Universitario Ramón y Cajal, Madrid, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Consulta de Urgencias Reumatológicas y Musculoesqueléticas, Servicio de Urgencias, Hospital Universitario Ramón y Cajal, Madrid, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Servicio de Urgencias, Hospital Universitario Ramón y Cajal, Madrid, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "¿Es seguro realizar infiltraciones o aspiraciones articulares en pacientes anticoagulados con acenocumarol?" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">The diagnostic and therapeutic treatment of patients with joint disease in the emergency room often includes the need for joint or perijoint<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> punctures. Anticoagulant treatment is often an impediment to these procedures because of the risk of bleeding.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> This represents a significant obstacle to performing these procedures as it is estimated that around 12 per 1000 inhabitants in Spain are receiving oral anticoagulants.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> This resistance, however, does not seem to be supported in the few studies performed with warfarin<a class="elsevierStyleCrossRefs" href="#bib0010"><span class="elsevierStyleSup">2,4,5</span></a> and, on the other hand, delays diagnosis with the potential risk of irreparable joint damage or even death.<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1,6,7</span></a> No studies have been conducted to measure this risk in acenocoumarol users.</p><p id="par0010" class="elsevierStylePara elsevierViewall">The objective of this study is to determine the risk of complications related to the performance of joint puncture in patients who are on anticoagulant therapy with acenocoumarol at therapeutic doses.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Patients and Methods</span><p id="par0015" class="elsevierStylePara elsevierViewall">A retrospective study of the records of 760 patients in whom 901 arthrocentesis or joint infiltration procedures were performed between 2009 and 2013, done in 3 centers: Emergency Department of the Hospital Universitario Ramón y Cajal (Madrid), Comprehensive Diagnostic and Treatment Center “Francisco Diaz” (Alcalá de Henares) and “San Juan” (Arganda del Rey) Medical Center. All patients were receiving anticoagulant treatment with acenocoumarol. All records included had an analytical determination of the international normalized ratio (INR) coagulation on the same day of the procedure or before up to 24<span class="elsevierStyleHsp" style=""></span>h.</p><p id="par0020" class="elsevierStylePara elsevierViewall">804 arthrocentesis or infiltrations (89%) were performed in the Emergency Department of the Hospital Universitario Ramón y Cajal. The rest of the procedures were performed in the other 2 centers. In all the centers, patients had a notification mechanism for immediate complications, except in the “San Juan” (11 patients) Medical Center as the center itself has no means of urgent assessment and emergencies are referred to other institutions.</p><p id="par0025" class="elsevierStylePara elsevierViewall">The technique for performing the procedures followed no pattern or established protocol. In 12% of the procedures, ultrasound guidance in real time was used.</p><p id="par0030" class="elsevierStylePara elsevierViewall">Records were stratified into 2 groups according to the arbitrary criterion used in the largest series of patients treated with warfarin<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> as a function of having an INR equal to or greater than 2.0 or maintained below this figure. The use of low molecular weight heparins as replacement therapy in cases of suspension of acenocoumarol or the use of antiplatelet therapy was not considered.</p><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Study Variables</span><p id="par0035" class="elsevierStylePara elsevierViewall">Epidemiologic variables of patients, data on use of antiplatelet therapy and comorbidities were simultaneously collected. The main variables were clinically significant bleeding and significant joint pain within 30 days from the day of the procedure.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Definitions</span><p id="par0040" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Clinically significant bleeding:</span> bleeding during the period immediately following the procedure that required reversal of anticoagulation, hospitalization or surgery.</p><p id="par0045" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Clinically significant joint pain:</span> joint pain related to the procedure that has caused the patient to seek further medical evaluation.</p><p id="par0050" class="elsevierStylePara elsevierViewall">The assessment of the main variables was performed 24<span class="elsevierStyleHsp" style=""></span>h after the procedure, within 24<span class="elsevierStyleHsp" style=""></span>h and the thirtieth day after the procedure.</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Statistical Analysis</span><p id="par0055" class="elsevierStylePara elsevierViewall">Synthesized global baseline variables were analyzed using central descriptive statistics and dispersion measures. To determine the presence of confounding variables between the groups according to the number of INR, a Wilcoxon test was used for continuous variables and a Fisher's exact test for dichotomous variables. The complication rate per group was compared using Fisher's exact test. All statistical tests were 2-tailed with an alpha error of 0.05. For statistical analysis, the gstat program v2.0 (Biometrics Department, GlaxoSmithKline SA, Tres Cantos, Madrid) was used.</p></span></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Results</span><p id="par0060" class="elsevierStylePara elsevierViewall">Between 2009 and 2013 records of 901 infiltration procedures or arthrocentesis performed in 760 patients were reviewed.</p><p id="par0065" class="elsevierStylePara elsevierViewall">Most procedures were performed by a rheumatologist (77.6%) or a family physician (16.6%). 5.8% of the procedures were performed by orthopedic or rehabilitation physicians. The most frequently infiltrated or aspirated joints were the knee and shoulder. 58% of the procedures were performed on the knee, 40% on the shoulder and 2% on other joints. Seventy-two percent of the procedures were infiltrations, 14% were aspirations and 14% were aspirations and injections. Six hundred and thirty-three procedures were performed in patients with an INR≥2.0 and 268 in those with an INR<2.0. 100% of the infiltrations had a therapeutic indication. 88% of the arthrocentesis had a diagnostic indication, 10% a therapeutic indication and in 2% the indication was identified in the medical record.</p><p id="par0070" class="elsevierStylePara elsevierViewall">Of interest we noted that the INR values for the first group interval was 2.0–8.1, with an average of 2.9; SD: 1.6.</p><p id="par0075" class="elsevierStylePara elsevierViewall">Two clinically significant bleedings were recorded. Both occurred before the first 72<span class="elsevierStyleHsp" style=""></span>h of knee arthrocentesis (INR 3.4) and a shoulder infiltration (INR 1.9). Higher concentrations of clinically significant pain were not identified according to INR levels in any of the two groups. The mean INR of the patients who had clinically significant pain was 1.4 and 3.3 in the group INR<2.0 or ≥2.0, respectively.</p><p id="par0080" class="elsevierStylePara elsevierViewall"><a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a> summarizes the baseline characteristics of the 2 groups. No significant differences in the proportion of female patients, the mean age, comorbidities (hypertension, diabetes, renal failure) and use of antiplatelet agents were identified.</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0085" class="elsevierStylePara elsevierViewall">No statistically significant differences in the rate of clinically significant bleeding or the rate of clinically significant pain between the two groups (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>) were identified.</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0090" class="elsevierStylePara elsevierViewall">Of the 22 procedures performed on the patients with INR≥2.0 in whom there had been clinically significant pain, 17 (77.2%) were performed by rheumatologists, 3 (13.6%) by family physicians and one (4.5%) by an orthopedist. Of the 14 procedures performed in patients with INR<2.0; 9 (64.2%) were made by rheumatologists and 5 (35.7%) by family physicians. No statistically significant differences were identified in the development of complications depending on the specialist who performed the procedure (<span class="elsevierStyleItalic">P</span>>.05 for both comparisons).</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Discussion</span><p id="par0095" class="elsevierStylePara elsevierViewall">This is the first article in which complications related to the performance of joint puncture in anticoagulated patients with acenocoumarol are presented. According to our results, we believe that the use of acenocoumarol at therapeutic doses does not pose an increased risk of bleeding when performing arthrocentesis or infiltration and, therefore, delaying these procedures to reverse the INR is unnecessary. The few available studies with warfarin agree that there are no statistically significant differences in the rate of bleeding complications according to the INR at the time of the procedure.<a class="elsevierStyleCrossRefs" href="#bib0010"><span class="elsevierStyleSup">2,4,5</span></a> Both treatments, acenocoumarol and warfarin, act on coagulation factors dependent on vitamin K, differing primarily in that the half-life of warfarin is around 48<span class="elsevierStyleHsp" style=""></span>h, while that of acenocoumarol is 10<span class="elsevierStyleHsp" style=""></span>h.<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3,8,9</span></a></p><p id="par0100" class="elsevierStylePara elsevierViewall">The results of our study are consistent with those obtained by Ahmed and Gertner<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> in terms of early and late complications due to bleeding, but in our study, joint pain was much higher in both the groups. This increase could be explained by the fact that a significant proportion of the patients whose records were included came from an area where access to emergency re-evaluations is relatively easy. Both Thumboo and O’Duffy<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> and Salvati et al.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> performed prospective studies that had a small sample size, agreed that the rate of bleeding complications in patients using warfarin was low and confirmed the safety of these procedures without reversing anticoagulation.</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Limitations of the Study</span><p id="par0105" class="elsevierStylePara elsevierViewall">The first limitation of this study is its retrospective nature and the possibility of underreporting complications. The data collection model was based on the study of Ahmed and Gertner.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> We believe that the arbitrary definitions of the main variables are limited to circumstances of real clinical interest and the probability of underreporting is low and in any event within 2 homogeneous groups of patients.</p><p id="par0110" class="elsevierStylePara elsevierViewall">The second limitation is the lack of homogeneity of the groups according to the value of the INR. In our study, older age was observed in the group of patients with INR≥2. We do not believe that this difference justifies the slight increase in bleeding complications or the need for repeated pain assessment. By contrast, whereas no statistically significant differences were identified, a reduction in the age difference would play for a minor difference in the occurrence of these complications.</p><p id="par0115" class="elsevierStylePara elsevierViewall">Taking these two considerations into account, the sample size of our study is the largest ever published and it is the first study with patients using acenocoumarol; we believe our results can serve as a basis for considering that oral anticoagulation should not be a risk factor for the development of bleeding complications after joint puncture and, therefore, its performance should not delay the procedure when indicated.</p></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Ethical Responsibilities</span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Protection of human and animal subjects</span><p id="par0120" class="elsevierStylePara elsevierViewall">The authors declare that this research did not perform experiments on humans or animals.</p></span><span id="sec0080" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Confidentiality of data</span><p id="par0125" class="elsevierStylePara elsevierViewall">The authors declare that they have followed the protocols of their workplace regarding the publication of data from patients, and all patients included in the study have received sufficient information and gave written informed consent to participate in the study.</p></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Right to privacy and informed consent</span><p id="par0130" class="elsevierStylePara elsevierViewall">The authors have obtained informed consent from patients and/or subjects referred to in the article. This document is in the possession of the corresponding author.</p></span></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Conflict of Interest</span><p id="par0135" class="elsevierStylePara elsevierViewall">The authors declare no conflict of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:12 [ 0 => array:2 [ "identificador" => "xres411387" "titulo" => "Abstract" ] 1 => array:2 [ "identificador" => "xpalclavsec387026" "titulo" => "Keywords" ] 2 => array:2 [ "identificador" => "xres411388" "titulo" => "Resumen" ] 3 => array:2 [ "identificador" => "xpalclavsec387027" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:3 [ "identificador" => "sec0010" "titulo" => "Patients and Methods" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0015" "titulo" => "Study Variables" ] 1 => array:2 [ "identificador" => "sec0020" "titulo" => "Definitions" ] 2 => array:2 [ "identificador" => "sec0025" "titulo" => "Statistical Analysis" ] ] ] 6 => array:2 [ "identificador" => "sec0030" "titulo" => "Results" ] 7 => array:2 [ "identificador" => "sec0035" "titulo" => "Discussion" ] 8 => array:2 [ "identificador" => "sec0040" "titulo" => "Limitations of the Study" ] 9 => array:3 [ "identificador" => "sec0070" "titulo" => "Ethical Responsibilities" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0075" "titulo" => "Protection of human and animal subjects" ] 1 => array:2 [ "identificador" => "sec0080" "titulo" => "Confidentiality of data" ] 2 => array:2 [ "identificador" => "sec0060" "titulo" => "Right to privacy and informed consent" ] ] ] 10 => array:2 [ "identificador" => "sec0065" "titulo" => "Conflict of Interest" ] 11 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2014-01-02" "fechaAceptado" => "2014-03-10" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec387026" "palabras" => array:4 [ 0 => "Acenocoumarol" 1 => "Anticoagulation" 2 => "Arthrocentesis" 3 => "Joint injection" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec387027" "palabras" => array:4 [ 0 => "Acenocumarol" 1 => "Anticoagulación" 2 => "Artrocentesis" 3 => "Infiltración articular" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">The purpose of this study is to determine the rate of bleeding complications in patient's anticoagulated with acenocoumarol according to the international normalized ratio (INR) coagulation index. A cross-sectional study was performed with 901 charts of patients who underwent arthrocentesis or joint infiltration between 2009 and 2013; the charts were grouped on the basis of having an INR higher or lower than 2.0 (268 and 633, respectively). Comparisons were performed in terms of rates of early or late bleeding complications. A 0.37% rate of early bleeding complications (<24<span class="elsevierStyleHsp" style=""></span>h) was observed in the group of patients with INR<2 and 0.99% in the group of patients with INR≥2 (<span class="elsevierStyleItalic">P</span>=.47). Only one case of late complication was presented by bleeding between 24<span class="elsevierStyleHsp" style=""></span>h and 30 days, in the group of patients with INR≥2. We conclude that oral anticoagulation with acenocoumarol at therapeutic doses does not increase the risk of bleeding joint punctures.</p>" ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">El propósito del presente estudio es determinar la tasa de complicaciones por sangrado en pacientes anticoagulados con acenocumarol en función del índice normalizado internacional (INR) de coagulación. Se realizó un estudio retrospectivo con 901 registros de pacientes a quienes se les practicó una artrocentesis o infiltración articular entre 2009 y 2013, se agruparon los registros en función de tener un INR superior o inferior a 2,0 (268 y 633 registros, respectivamente) y se compararon las tasas de complicaciones por sangrado. Se observó una tasa de 0,37% de complicaciones por sangrado tempranas (<<span class="elsevierStyleHsp" style=""></span>24<span class="elsevierStyleHsp" style=""></span>h) en el grupo de pacientes con INR<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>2 y una tasa de 0,99% en el grupo de pacientes con INR<span class="elsevierStyleHsp" style=""></span>≥<span class="elsevierStyleHsp" style=""></span>2 (p<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0,47). Solo se presentó un caso de complicación por sangrado tardío, entre 24<span class="elsevierStyleHsp" style=""></span>h y 30 días, en el grupo de pacientes con INR<span class="elsevierStyleHsp" style=""></span>≥<span class="elsevierStyleHsp" style=""></span>2. Concluimos que la anticoagulación oral a dosis terapéutica con acenocumarol no incrementa el riesgo de sangrado por punciones articulares.</p>" ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Guillen Astete C, Boteanu A, Medina Quiñones C, Garcia Montes N, Roldan Moll F, Carballo Carmano C, et al. ¿Es seguro realizar infiltraciones o aspiraciones articulares en pacientes anticoagulados con acenocumarol? Reumatol Clin. 2015;11:9–11.</p>" ] ] "multimedia" => array:2 [ 0 => array:7 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">INR<2.0n=268 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">INR≥2.0n=633 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">P</span> value \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Age<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>SD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">68<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">71<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top"><.05 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Proportion of female gender \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">51% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">59% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.25 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Comorbidity: diabetes \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">12% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">18% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.28 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Comorbidity: hypertension \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">58% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">61% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.66 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Comorbidity: renal failure \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">6% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.75 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Proportion of patients treated with antiplatelet therapy \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">51% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">55% \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">.57 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab639758.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Baseline Characteristics of Patients in Whom the Procedures Studied Were Performed.</p>" ] ] 1 => array:7 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">INR<2.0 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">INR≥2.0 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">P</span> value \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Clinically significant bleeding (early) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (0.37%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (0.99%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">NS \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Clinically significant bleeding (late) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (0.99%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">NS \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Significant joint pain \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">14 (5.22%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">22 (3.44%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">NS \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab639757.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Comparison of the Rate of Complications per Group, According to INR.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:9 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "BSR & BHPR, BOA, RCGP and BSAC guidelines for management of the hot swollen joint in adults" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G. Coakley" 1 => "C. Mathews" 2 => "M. Campo" 3 => "A. Jones" 4 => "G. Kingsley" 5 => "D. Walker" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rheumatology (Oxford)" "fecha" => "2006" "volumen" => "45" "paginaInicial" => "1039" "paginaFinal" => "1041" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Safety of arthrocentesis and joint injection in patients receiving anticoagulation at therapeutic levels" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "I. Ahmed" 1 => "E. Gertner" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.amjmed.2011.08.022" "Revista" => array:6 [ "tituloSerie" => "Am J Med" "fecha" => "2012" "volumen" => "125" "paginaInicial" => "265" "paginaFinal" => "269" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22340924" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tratamiento anticoagulante oral. Estudio coste/beneficio" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "J. Navarro" 1 => "M. Fernández" 2 => "J. Fontcuberta" 3 => "J. Reverter" 4 => "J. Gol-Freixase" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Rev Adm Sanit" "fecha" => "2008" "volumen" => "6" "paginaInicial" => "525" "paginaFinal" => "542" "itemHostRev" => array:3 [ "pii" => "S0959804908005479" "estado" => "S300" "issn" => "09598049" ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A prospective study of the safety of joint and soft tissue aspirations and injections in patients taking warfarin sodium" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J. Thumboo" 1 => "J.D. O’Duffy" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/1529-0131(199804)41:4<736::AID-ART23>3.0.CO;2-P" "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "1998" "volumen" => "41" "paginaInicial" => "736" "paginaFinal" => "739" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9550485" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Frequency of the bleeding risk in patients receiving warfarin submitted to arthrocentesis of the knee" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G. Salvati" 1 => "L. Punzi" 2 => "M. Pianon" 3 => "C. Valvason" 4 => "F. Schiavon" 5 => "N. Noal" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Reumatismo" "fecha" => "2003" "volumen" => "55" "paginaInicial" => "159" "paginaFinal" => "163" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14513115" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evidence-based diagnostics: adult septic arthritis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "C.R. Carpenter" 1 => "J.D. Schuur" 2 => "W.W. Everett" 3 => "J.M. Pines" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1553-2712.2011.01121.x" "Revista" => array:6 [ "tituloSerie" => "Acad Emerg Med" "fecha" => "2011" "volumen" => "18" "paginaInicial" => "781" "paginaFinal" => "796" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21843213" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Septic arthritis: current diagnostic and therapeutic algorithm" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "C.J. Mathews" 1 => "G. Coakley" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/BOR.0b013e3283036975" "Revista" => array:6 [ "tituloSerie" => "Curr Opin Rheumatol" "fecha" => "2008" "volumen" => "20" "paginaInicial" => "457" "paginaFinal" => "462" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18525361" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacogenetics of oral anticoagulants: a basis for dose individualization" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "S. Stehle" 1 => "J. Kirchheiner" 2 => "A. Lazar" 3 => "U. Fuhr" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Clin Pharmacokinet" "fecha" => "2008" "volumen" => "47" "paginaInicial" => "565" "paginaFinal" => "594" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18698879" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "M. Beinema" 1 => "J.R.B.J. Brouwers" 2 => "T. Schalekamp" 3 => "B. Wilffert" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Thromb Haemost" "fecha" => "2008" "volumen" => "100" "paginaInicial" => "1052" "paginaFinal" => "1057" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19132230" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735743/0000001100000001/v1_201501160858/S2173574314001129/v1_201501160858/en/main.assets" "Apartado" => array:4 [ "identificador" => "17338" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Original Article" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/21735743/0000001100000001/v1_201501160858/S2173574314001129/v1_201501160858/en/main.pdf?idApp=UINPBA00004M&text.app=https://www.reumatologiaclinica.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574314001129?idApp=UINPBA00004M" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 October | 33 | 13 | 46 |
2024 September | 64 | 14 | 78 |
2024 August | 72 | 38 | 110 |
2024 July | 96 | 33 | 129 |
2024 June | 61 | 26 | 87 |
2024 May | 66 | 23 | 89 |
2024 April | 78 | 25 | 103 |
2024 March | 45 | 35 | 80 |
2024 February | 42 | 31 | 73 |
2024 January | 36 | 24 | 60 |
2023 December | 26 | 30 | 56 |
2023 November | 43 | 50 | 93 |
2023 October | 40 | 30 | 70 |
2023 September | 75 | 47 | 122 |
2023 August | 82 | 23 | 105 |
2023 July | 35 | 26 | 61 |
2023 June | 24 | 27 | 51 |
2023 May | 46 | 27 | 73 |
2023 April | 25 | 14 | 39 |
2023 March | 58 | 26 | 84 |
2023 February | 82 | 26 | 108 |
2023 January | 43 | 24 | 67 |
2022 December | 58 | 45 | 103 |
2022 November | 42 | 38 | 80 |
2022 October | 47 | 34 | 81 |
2022 September | 54 | 34 | 88 |
2022 August | 47 | 50 | 97 |
2022 July | 47 | 33 | 80 |
2022 June | 43 | 33 | 76 |
2022 May | 59 | 45 | 104 |
2022 April | 78 | 51 | 129 |
2022 March | 52 | 49 | 101 |
2022 February | 46 | 52 | 98 |
2022 January | 36 | 51 | 87 |
2021 December | 40 | 31 | 71 |
2021 November | 64 | 34 | 98 |
2021 October | 56 | 51 | 107 |
2021 September | 41 | 48 | 89 |
2021 August | 41 | 46 | 87 |
2021 July | 31 | 28 | 59 |
2021 June | 40 | 33 | 73 |
2021 May | 40 | 38 | 78 |
2021 April | 63 | 87 | 150 |
2021 March | 57 | 29 | 86 |
2021 February | 29 | 15 | 44 |
2021 January | 37 | 40 | 77 |
2020 December | 34 | 19 | 53 |
2020 November | 62 | 24 | 86 |
2020 October | 50 | 8 | 58 |
2020 September | 39 | 21 | 60 |
2020 August | 43 | 20 | 63 |
2020 July | 36 | 16 | 52 |
2020 June | 68 | 11 | 79 |
2020 May | 53 | 22 | 75 |
2020 April | 22 | 21 | 43 |
2020 March | 16 | 5 | 21 |
2020 February | 2 | 0 | 2 |
2018 May | 4 | 0 | 4 |
2018 April | 79 | 15 | 94 |
2018 March | 128 | 11 | 139 |
2018 February | 66 | 7 | 73 |
2018 January | 53 | 7 | 60 |
2017 December | 74 | 9 | 83 |
2017 November | 79 | 8 | 87 |
2017 October | 51 | 6 | 57 |
2017 September | 66 | 7 | 73 |
2017 August | 77 | 14 | 91 |
2017 July | 73 | 14 | 87 |
2017 June | 90 | 18 | 108 |
2017 May | 92 | 11 | 103 |
2017 April | 79 | 9 | 88 |
2017 March | 82 | 10 | 92 |
2017 February | 43 | 6 | 49 |
2017 January | 52 | 10 | 62 |
2016 December | 88 | 15 | 103 |
2016 November | 87 | 6 | 93 |
2016 October | 131 | 17 | 148 |
2016 September | 112 | 12 | 124 |
2016 August | 71 | 2 | 73 |
2016 July | 45 | 8 | 53 |
2016 April | 2 | 0 | 2 |
2016 March | 1 | 0 | 1 |
2015 December | 2 | 0 | 2 |
2015 September | 2 | 0 | 2 |
2015 August | 2 | 0 | 2 |
2015 July | 30 | 10 | 40 |
2015 June | 49 | 11 | 60 |
2015 May | 88 | 18 | 106 |
2015 April | 80 | 18 | 98 |
2015 March | 79 | 9 | 88 |
2015 February | 78 | 19 | 97 |
2015 January | 54 | 13 | 67 |